nepafenac has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inanc, M; Kiziltoprak, H; Koc, M; Ozulken, K; Tekin, K; Yetkin, E | 1 |
| Aaronson, A; Danni, R; Tuuminen, R; Viljanen, A | 1 |
1 trial(s) available for nepafenac and Diabetes Mellitus
| Article | Year |
|---|---|
Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Benzeneacetamides; Cataract Extraction; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Postoperative Care; Postoperative Complications; Prednisolone; Preoperative Care; Prospective Studies; Tomography, Optical Coherence | 2019 |
1 other study(ies) available for nepafenac and Diabetes Mellitus
| Article | Year |
|---|---|
Additive Effect of Topical Nepafenac on Mydriasis in Patients With Diabetes Mellitus.
Topics: Benzeneacetamides; Diabetes Mellitus; Humans; Mydriasis; Phenylacetates; Prospective Studies; Pupil | 2020 |